Metabolomics in Pharmaceutical research


The later that a molecule or molecular class is lost from the drug development pipeline, the higher the financial cost. Minimizing attrition is therefore one of the most important aims of a pharmaceutical discovery programme.

Novel technologies that increase the probability of making the right choice early save resources, and promote safety, efficacy and profitability.

Metabolomics is a systems approach for studying in vivo metabolic profiles, which promises to provide information on drug toxicity, disease processes and gene function at several stages in the discovery and-development process.